241 related articles for article (PubMed ID: 25808416)
1. Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies.
Cardoso I; Stamnaes J; Andersen JT; Melino G; Iversen R; Sollid LM
FEBS J; 2015 Jun; 282(11):2063-75. PubMed ID: 25808416
[TBL] [Abstract][Full Text] [Related]
2. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
Stamnaes J; Cardoso I; Iversen R; Sollid LM
FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells.
Iversen R; Di Niro R; Stamnaes J; Lundin KE; Wilson PC; Sollid LM
J Immunol; 2013 Jun; 190(12):5981-91. PubMed ID: 23690478
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
Chen X; Hnida K; Graewert MA; Andersen JT; Iversen R; Tuukkanen A; Svergun D; Sollid LM
J Biol Chem; 2015 Aug; 290(35):21365-75. PubMed ID: 26160175
[TBL] [Abstract][Full Text] [Related]
6. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
Rauhavirta T; Hietikko M; Salmi T; Lindfors K
Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
[TBL] [Abstract][Full Text] [Related]
8. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the interaction between transglutaminase 2 and fibronectin.
Cardoso I; Østerlund EC; Stamnaes J; Iversen R; Andersen JT; Jørgensen TJ; Sollid LM
Amino Acids; 2017 Mar; 49(3):489-500. PubMed ID: 27394141
[TBL] [Abstract][Full Text] [Related]
10. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
[TBL] [Abstract][Full Text] [Related]
11. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
Simon-Vecsei Z; Király R; Bagossi P; Tóth B; Dahlbom I; Caja S; Csosz É; Lindfors K; Sblattero D; Nemes É; Mäki M; Fésüs L; Korponay-Szabó IR
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):431-6. PubMed ID: 22198767
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042
[TBL] [Abstract][Full Text] [Related]
13. Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling.
Wang Z; Collighan RJ; Pytel K; Rathbone DL; Li X; Griffin M
J Biol Chem; 2012 Apr; 287(16):13063-83. PubMed ID: 22298777
[TBL] [Abstract][Full Text] [Related]
14. Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy.
Lindstad CB; du Pré MF; Stamnaes J; Sollid LM
PLoS One; 2022; 17(4):e0266543. PubMed ID: 35385534
[TBL] [Abstract][Full Text] [Related]
15. Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.
Kalliokoski S; Sulic AM; Korponay-Szabó IR; Szondy Z; Frias R; Perez MA; Martucciello S; Roivainen A; Pelliniemi LJ; Esposito C; Griffin M; Sblattero D; Mäki M; Kaukinen K; Lindfors K; Caja S
PLoS One; 2013; 8(6):e65887. PubMed ID: 23824706
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 has higher affinity for relaxed than for stretched fibronectin fibers.
Selcuk K; Leitner A; Braun L; Le Blanc F; Pacak P; Pot S; Vogel V
Matrix Biol; 2024 Jan; 125():113-132. PubMed ID: 38135164
[TBL] [Abstract][Full Text] [Related]
17. Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease.
Di Niro R; Snir O; Kaukinen K; Yaari G; Lundin KE; Gupta NT; Kleinstein SH; Cols M; Cerutti A; Mäki M; Shlomchik MJ; Sollid LM
Mucosal Immunol; 2016 Jan; 9(1):254-64. PubMed ID: 26153762
[TBL] [Abstract][Full Text] [Related]
18. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
Paolella G; Sposito S; Romanelli AM; Caputo I
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
[TBL] [Abstract][Full Text] [Related]
19. Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2.
Nadalutti CA; Korponay-Szabo IR; Kaukinen K; Griffin M; Mäki M; Lindfors K
Cell Mol Life Sci; 2014 Apr; 71(7):1315-26. PubMed ID: 23982754
[TBL] [Abstract][Full Text] [Related]
20. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]